We are live on ! Find out more
ES

Enavate Sciences Portfolio holdings

AUM $352M
1-Year Est. Return 220.14%
This Fund
S&P 500
This Quarter Est. Return
+44.71%
1 Year Est. Return
+220.14%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$177M
AUM Growth
+$43.8M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMNM icon
1
Immunome
IMNM
$2.58B
$44.3M 25.12%
4,768,583
– –
SION
2
Sionna Therapeutics
SION
$2.13B
$43M 24.35%
2,478,030
– –
ZBIO
3
Zenas BioPharma
ZBIO
$1.98B
$36.4M 20.65%
3,761,359
– –
UPB
4
Upstream Bio Inc
UPB
$343M
$27M 15.3%
2,459,703
– –
CMPX icon
5
Compass Therapeutics
CMPX
$344M
$20.2M 11.47%
7,788,150
– –
CAMP icon
6
CAMP4 Therapeutics
CAMP
$179M
$5.49M 3.11%
3,785,802
– –

Similar funds

HIA
HTG Investment Advisors New Canaan, Connecticut $352M AUM 17.26% 1-Year Est. Return
AW
Alaethes Wealth Glenbrook, Nevada $351M AUM 22.79% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
PIC
PCJ Investment Counsel Toronto, Ontario, Canada $352M AUM 68.32% 1-Year Est. Return
FFO
Fiduciary Family Office Boca Raton, Florida $351M AUM 22.19% 1-Year Est. Return
EC
Elmind Capital New York $352M AUM
SMC
Spider Management Company Richmond, Virginia $351M AUM 18.35% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return

Enavate Sciences's Q2 2025 Portfolio in Review

As of Q2 2025, Enavate Sciences held 6 positions worth $177M, up 33% from $133M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2025: portfolio turnover was 0%. Enavate Sciences opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Enavate Sciences's ten largest holdings make up 100% of its $177M portfolio in Q2 2025.
  • Enavate Sciences opened 0 new positions and closed 0 in Q2 2025.
  • Enavate Sciences's portfolio value rose 33% quarter-over-quarter to $177M.

Based on Enavate Sciences's 13F filing for Q2 2025, filed 14 Aug 2025.